Advancements in Hematopoietic stem Cell Transplantation

In a notable stride for medical treatment in vietnam, the Dà Nang Hospital has announced the accomplished completion of a stem cell autograft procedure for a patient battling multiple myeloma. This marks the third such procedure performed at the hospital, highlighting the growing expertise and accessibility of advanced cancer treatments within the region.

Understanding Autologous Stem Cell Transplants

Autologous stem cell transplantation (ASCT) is a procedure used in the treatment of certain cancers, including multiple myeloma, lymphoma, and leukemia. The process involves harvesting the patientS own stem cells, administering high-dose chemotherapy too eradicate cancerous cells, and then reinfusing the previously collected stem cells to rebuild the patient’s hematopoietic system.

This treatment allows the patient to recieve much higher dose chemotherapy treatments than usual.Reinjection of stem cells helps regenerate blood cells after treatment at high doses of chemotherapy.

This approach allows for the delivery of chemotherapy doses that would otherwise be too toxic for the body to handle. The reinfused stem cells then act as a seed, repopulating the bone marrow and restoring the patient’s ability to produce healthy blood cells.

Da Nang Hospital’s Growing Expertise

dr. Trân Thi Thanh Huong, the lead physician involved in the procedure, emphasized the importance of this advanced treatment method. According to Dr. Huong, the autograft rapidly restores the patient’s hematopoietic system following intense chemotherapy, mitigating the risk of potentially life-threatening complications. The hospital’s increasing proficiency in this technique offers a lifeline to patients with severe blood disorders in central Vietnam and the Central Highlands.

This technique offers significant chances of survival and improves the quality of life of patients with malignant hemopathies such as lymphoma, myeloproliferative disorders, multiple myeloma and leukemia.

Dr. Trân Thi Thanh Huong, Dà Nang hospital

The Dà Nang hospital successfully performed its first autologous stem cell transplant in 2023, with support from the National Institute of Hematology and Blood Transfusion. The consistent request of this technique underscores the growing competence of the hospital’s medical staff and provides renewed hope for patients facing serious hematological conditions.

The Broader Context of Multiple Myeloma Treatment

Multiple myeloma is a cancer that forms in plasma cells, a type of white blood cell responsible for producing antibodies. While ASCT is a crucial treatment option, it’s often used in conjunction with other therapies, such as chemotherapy, targeted therapy, and immunotherapy. According to the American Cancer Society, the five-year survival rate for multiple myeloma has been steadily improving, thanks to advancements in treatment options like stem cell transplantation.

The success at Dà Nang Hospital reflects a broader trend of increasing access to advanced medical care in Vietnam, offering new possibilities for patients battling complex diseases.